Total Payments
$833,709
2024 Payments
$119,704
Companies
19
Transactions
603
Medicare Patients
2,065
Medicare Billing
$352,962
Payment Breakdown by Category
Other$409,200 (49.1%)
Consulting$236,904 (28.4%)
Travel$129,928 (15.6%)
Research$43,819 (5.3%)
Food & Beverage$13,748 (1.6%)
Education$108.84 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $408,031 | 141 | 48.9% |
| Consulting Fee | $236,904 | 70 | 28.4% |
| Travel and Lodging | $129,928 | 189 | 15.6% |
| Unspecified | $43,819 | 4 | 5.3% |
| Food and Beverage | $13,748 | 194 | 1.6% |
| Grant | $1,070 | 2 | 0.1% |
| Education | $108.84 | 2 | 0.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $100.00 | 1 | 0.0% |
Payments by Type
General
$789,890
599 transactions
Research
$43,819
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $311,966 | 245 | $0 (2024) |
| Celgene Corporation | $148,871 | 93 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $120,435 | 36 | $0 (2024) |
| GlaxoSmithKline, LLC. | $75,265 | 33 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $52,645 | 39 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $51,896 | 66 | $0 (2024) |
| Amgen Inc. | $21,271 | 20 | $0 (2022) |
| PFIZER INC. | $16,858 | 12 | $0 (2024) |
| Millennium Pharmaceuticals, Inc. | $15,847 | 9 | $0 (2017) |
| AbbVie Inc. | $9,928 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $119,704 | 89 | Janssen Biotech, Inc. ($92,953) |
| 2023 | $102,080 | 87 | Janssen Biotech, Inc. ($73,829) |
| 2022 | $123,584 | 75 | Janssen Biotech, Inc. ($64,646) |
| 2021 | $82,995 | 50 | GlaxoSmithKline, LLC. ($42,495) |
| 2020 | $62,134 | 28 | Takeda Pharmaceuticals U.S.A., Inc. ($26,521) |
| 2019 | $106,546 | 68 | Takeda Pharmaceuticals U.S.A., Inc. ($42,339) |
| 2018 | $154,141 | 134 | Celgene Corporation ($60,058) |
| 2017 | $82,526 | 72 | Celgene Corporation ($44,145) |
All Payment Transactions
603 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | ELREXFIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,275.00 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $91.79 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $136.44 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $96.86 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | ABECMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,397.00 | General |
| Category: Oncology | ||||||
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | ABECMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,082.00 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,070.00 | General |
| Category: Oncology | ||||||
| 11/23/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $255.96 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $302.45 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $573.58 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,070.00 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $113.17 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $850.63 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $122.88 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,390.00 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Oncology | ||||||
| 10/18/2024 | E.R. Squibb & Sons, L.L.C. | ABECMA (Biological) | Travel and Lodging | Cash or cash equivalent | $724.00 | General |
| Category: Oncology | ||||||
| 10/18/2024 | E.R. Squibb & Sons, L.L.C. | ABECMA (Biological) | Travel and Lodging | Cash or cash equivalent | $721.39 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $757.74 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $675.00 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CC-5013-MM-036 - Connect MM- The Multiple Myeloma Disease Registry | Celgene Corporation | $18,300 | 1 |
| CC-5013-MM-036 | Celgene Corporation | $10,807 | 1 |
| Connect MM- The Multiple Myeloma Disease Registry (CC-5013-MM-036) | Celgene Corporation | $10,166 | 1 |
| Study of Dexamethasone Plus IXAZOMIB MLN9708 or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain AL Amyloidosis | Takeda Pharmaceuticals U.S.A., Inc. | $4,546 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 567 | 1,413 | $323,788 | $100,385 |
| 2022 | 7 | 480 | 1,258 | $289,366 | $88,471 |
| 2021 | 6 | 524 | 1,274 | $288,842 | $91,340 |
| 2020 | 5 | 494 | 1,129 | $255,240 | $72,765 |
Total Patients
2,065
Total Services
5,074
Medicare Billing
$352,962
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 392 | 1,099 | $237,384 | $73,200 | 30.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 163 | $35,371 | $14,444 | 40.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 29 | 38 | $11,134 | $3,835 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 39 | 39 | $12,207 | $3,742 | 30.7% |
| 38220 | Aspiration of bone marrow sample for diagnosis | Facility | 2023 | 51 | 56 | $20,384 | $2,790 | 13.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 18 | 18 | $7,308 | $2,375 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 349 | 1,059 | $228,744 | $71,649 | 31.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 84 | $18,228 | $6,254 | 34.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 28 | 28 | $11,368 | $3,716 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 23 | 27 | $7,911 | $2,951 | 37.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 22 | 22 | $6,886 | $1,966 | 28.6% |
| 38220 | Aspiration of bone marrow sample for diagnosis | Facility | 2022 | 20 | 21 | $7,644 | $1,068 | 14.0% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2022 | 17 | 17 | $8,585 | $865.76 | 10.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 355 | 994 | $214,704 | $70,168 | 32.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 31 | 134 | $29,078 | $10,329 | 35.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 40 | 40 | $16,240 | $5,339 | 32.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 21 | 21 | $6,573 | $2,069 | 31.5% |
| 38222 | Diagnostic aspirations and biopsies of bone marrow | Facility | 2021 | 23 | 26 | $13,130 | $1,533 | 11.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 36 | 39 | $4,797 | $1,030 | 21.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 20 | $4,320 | $871.84 | 20.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 306 | 754 | $162,864 | $43,065 | 26.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 35 | 213 | $46,221 | $17,091 | 37.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 64 | 64 | $25,984 | $7,964 | 30.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 46 | 50 | $4,890 | $1,884 | 38.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 31 | $6,696 | $1,728 | 25.8% |
About Dr. Rafat Abonour, MD
Dr. Rafat Abonour, MD is a Internal Medicine healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750346755.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rafat Abonour, MD has received a total of $833,709 in payments from pharmaceutical and medical device companies, with $119,704 received in 2024. These payments were reported across 603 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($408,031).
As a Medicare-enrolled provider, Abonour has provided services to 2,065 Medicare beneficiaries, totaling 5,074 services with total Medicare billing of $352,962. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology, Hematology
- Location Indianapolis, IN
- Active Since 04/20/2006
- Last Updated 03/05/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1750346755
Products in Payments
- DARZALEX (Biological) $294,234
- BLENREP (Biological) $73,665
- NINLARO (Drug) $62,514
- TECVAYLI (Biological) $53,757
- Revlimid (Drug) $48,347
- ABECMA (Biological) $22,969
- Kyprolis (Drug) $19,640
- CARVYKTI (Drug) $12,612
- Pomalyst (Drug) $11,695
- ELREXFIO (Drug) $8,508
- VENCLEXTA (Drug) $4,920
- Ninlaro (Drug) $4,546
- clonoSEQ (Device) $2,940
- Venclexta (Drug) $1,708
- NO PRODUCT DISCUSSED (Drug) $1,311
- DARZALEX (Drug) $132.55
- EMPLICITI (Biological) $125.00
- Epkinly (Drug) $124.23
- Yescarta (Drug) $121.88
- XPOVIO (Drug) $113.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Indianapolis
David Batt, Md, MD
Internal Medicine — Payments: $682,018
Internal Medicine $682,018
Ashwin Ravichandran, Md, MD
Internal Medicine — Payments: $398,583
Internal Medicine $398,583
John Miller, Md, MD
Internal Medicine — Payments: $325,524
Internal Medicine $325,524
Naga Chalasani, Md, MD
Internal Medicine — Payments: $303,095
Internal Medicine $303,095
James Trippi, Md, MD
Internal Medicine — Payments: $280,481
Internal Medicine $280,481
Dr. Woodrow Corey, Md, MD
Internal Medicine — Payments: $262,512
Internal Medicine $262,512